Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Truong

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
AIDS Research and Human Retroviruses|September 10, 1999
Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern ChinaK Kato, T Shiino, S Kusagawa, et al.
European Heart Journal. Digital Health|January 24, 2024
CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)Anh T L Truong, Shi-Bei Tan, Golda Z Wang, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
British Journal of Cancer|March 22, 2024
Radiation therapy with phenotypic medicine: towards N-of-1 personalizationLi Ming Chong, Peter Wang, V Vien Lee, et al.
Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
ACS Nano|August 17, 2022
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 InterventionAgata Blasiak, Anh T L Truong, Peter Wang, et al.
Cell Reports. Medicine|March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamstersMichael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
JCO Oncology Practice|October 14, 2022
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated CourseDarragh F O'Donoghue, Huong L Truong, Heidi D Finnes, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
AIDS Research and Human Retroviruses|September 10, 1999
Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern ChinaK Kato, T Shiino, S Kusagawa, et al.
European Heart Journal. Digital Health|January 24, 2024
CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)Anh T L Truong, Shi-Bei Tan, Golda Z Wang, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
British Journal of Cancer|March 22, 2024
Radiation therapy with phenotypic medicine: towards N-of-1 personalizationLi Ming Chong, Peter Wang, V Vien Lee, et al.
Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
ACS Nano|August 17, 2022
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 InterventionAgata Blasiak, Anh T L Truong, Peter Wang, et al.
Cell Reports. Medicine|March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamstersMichael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
JCO Oncology Practice|October 14, 2022
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated CourseDarragh F O'Donoghue, Huong L Truong, Heidi D Finnes, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
Pageof 29